Neurocrine Biosciences, Inc. (NBIX)
153.04
+0.47
(+0.31%)
USD |
NASDAQ |
Aug 24, 16:00
153.04
0.00 (0.00%)
After-Hours: 19:20
Neurocrine Biosciences Shareholders Equity (Quarterly) : 3.694B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.694B |
| March 31, 2026 | 3.407B |
| December 31, 2025 | 3.253B |
| September 30, 2025 | 3.004B |
| June 30, 2025 | 2.694B |
| March 31, 2025 | 2.536B |
| December 31, 2024 | 2.590B |
| September 30, 2024 | 2.719B |
| June 30, 2024 | 2.509B |
| March 31, 2024 | 2.386B |
| December 31, 2023 | 2.232B |
| September 30, 2023 | 2.002B |
| June 30, 2023 | 1.853B |
| March 31, 2023 | 1.684B |
| December 31, 2022 | 1.708B |
| September 30, 2022 | 1.545B |
| June 30, 2022 | 1.423B |
| March 31, 2022 | 1.391B |
| December 31, 2021 | 1.374B |
| September 30, 2021 | 1.346B |
| June 30, 2021 | 1.279B |
| March 31, 2021 | 1.206B |
| December 31, 2020 | 1.126B |
| September 30, 2020 | 804.30M |
| June 30, 2020 | 831.20M |
| Date | Value |
|---|---|
| March 31, 2020 | 700.30M |
| December 31, 2019 | 636.92M |
| September 30, 2019 | 574.52M |
| June 30, 2019 | 483.71M |
| March 31, 2019 | 409.28M |
| December 31, 2018 | 480.76M |
| September 30, 2018 | 447.51M |
| June 30, 2018 | 377.44M |
| March 31, 2018 | 364.49M |
| December 31, 2017 | 372.14M |
| September 30, 2017 | 347.51M |
| June 30, 2017 | 345.24M |
| March 31, 2017 | 247.14M |
| December 31, 2016 | 314.88M |
| September 30, 2016 | 351.65M |
| June 30, 2016 | 381.04M |
| March 31, 2016 | 412.96M |
| December 31, 2015 | 424.45M |
| September 30, 2015 | 446.94M |
| June 30, 2015 | 466.94M |
| March 31, 2015 | 484.73M |
| December 31, 2014 | 208.70M |
| September 30, 2014 | 224.04M |
| June 30, 2014 | 236.84M |
| March 31, 2014 | 247.06M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amarin Corp. Plc | 443.62M |
| Liquidia Corp. | 195.11M |
| Incyte Corp. | 6.344B |
| Krystal Biotech, Inc. | 1.359B |
| Halozyme Therapeutics, Inc. | 143.54M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.359B |
| Total Liabilities (Quarterly) | 1.666B |
| Debt to Equity Ratio | 0.1088 |
| Current Ratio | 1.872 |
| Net Debt Paydown Yield | 0.11% |